McDonald's is considering changes to its offer due to the increasing use of drugs from the GLP-1 group, including Ozempik and Vegovi. The company is examining smaller and more customizable portions, meals with more protein and offers with less sugar, as millions of Americans are changing their diet under the influence of these preparations, "finance.yahoo.com" reports. McDonald's CEO Chris Kempczynski said that […]
The article Less appetite, sma…